117 related articles for article (PubMed ID: 35414501)
1. Transcriptional Profile of HCV Replicon Cells after Treatment with Acetylsalicylic Acid.
Rios-Ibarra CP; Verduzco-Garza B; Ortiz-Lopez R; Grondin Y; Salinas-Santander M; Arvizu-Gutierrez LA; Sanchez-Salazar MG; Cervantes-Astorga E; Orozco-Nunnelly DA; Rivas-Estilla AM
Ann Clin Lab Sci; 2022 Mar; 52(2):222-229. PubMed ID: 35414501
[TBL] [Abstract][Full Text] [Related]
2. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
[TBL] [Abstract][Full Text] [Related]
3. Cu/Zn superoxide dismutase (SOD1) induction is implicated in the antioxidative and antiviral activity of acetylsalicylic acid in HCV-expressing cells.
Rivas-Estilla AM; Bryan-Marrugo OL; Trujillo-Murillo K; Pérez-Ibave D; Charles-Niño C; Pedroza-Roldan C; Ríos-Ibarra C; Ramírez-Valles E; Ortiz-López R; Islas-Carbajal MC; Nieto N; Rincón-Sánchez AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1264-73. PubMed ID: 22442156
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones.
Ciccaglione AR; Marcantonio C; Tritarelli E; Tataseo P; Ferraris A; Bruni R; Dallapiccola B; Gerosolimo G; Costantino A; Rapicetta M
BMC Genomics; 2008 Jun; 9():309. PubMed ID: 18590516
[TBL] [Abstract][Full Text] [Related]
5. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells.
Lozano-Sepulveda SA; Bautista-Osorio E; Merino-Mascorro JA; Varela-Rey M; Muñoz-Espinosa LE; Cordero-Perez P; Martinez-Chantar ML; Rivas-Estilla AM
World J Gastroenterol; 2016 Apr; 22(14):3746-57. PubMed ID: 27076759
[TBL] [Abstract][Full Text] [Related]
6. Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES).
Torrecilla J; Del Pozo-Rodríguez A; Solinís MÁ; Apaolaza PS; Berzal-Herranz B; Romero-López C; Berzal-Herranz A; Rodríguez-Gascón A
Colloids Surf B Biointerfaces; 2016 Oct; 146():808-17. PubMed ID: 27451369
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
9. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
Yu M; Peng B; Chan K; Gong R; Yang H; Delaney W; Cheng G
Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
11. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
Abe K; Ikeda M; Dansako H; Naka K; Shimotohno K; Kato N
Virus Res; 2005 Jan; 107(1):73-81. PubMed ID: 15567036
[TBL] [Abstract][Full Text] [Related]
12. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
Whitmill A; Kim S; Rojas V; Gulraiz F; Afreen K; Jain M; Singh M; Park IW
PLoS One; 2018; 13(8):e0202524. PubMed ID: 30138348
[TBL] [Abstract][Full Text] [Related]
13. [Replication of the subgenomic hepatitis C virus replicon in the presence of the NS3 protease inhibitors: a stochastic model].
Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Samsonova MG; Samsonov AM; Kolchanov NA; Ivanisenko VA
Biofizika; 2013; 58(5):758-74. PubMed ID: 25481944
[TBL] [Abstract][Full Text] [Related]
14. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
[TBL] [Abstract][Full Text] [Related]
15. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
Trujillo-Murillo K; Alvarez-Martínez O; Garza-Rodríguez L; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña H; Rincón-Sánchez AR; Rivas-Estilla AM
J Viral Hepat; 2007 Sep; 14(9):608-17. PubMed ID: 17697012
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.
Frese M; Pietschmann T; Moradpour D; Haller O; Bartenschlager R
J Gen Virol; 2001 Apr; 82(Pt 4):723-733. PubMed ID: 11257176
[TBL] [Abstract][Full Text] [Related]
19. A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.
Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Gursky VV; Samsonova MG; Samsonov AM; Clausznitzer D; Kaderali L; Kolchanov NA; Ivanisenko VA
PLoS One; 2014; 9(3):e91502. PubMed ID: 24643004
[TBL] [Abstract][Full Text] [Related]
20. Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid.
Sánchez-García A; Ríos-Ibarra CP; Rincón-Sánchez AR; Ortiz-López R; Garza-Juárez A; Morlett-Chávez J; Martínez-Rodríguez H; Rivas-Estilla AM
Ann Hepatol; 2013; 12(5):725-32. PubMed ID: 24018490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
